CD38 expression, a T cell activation marker with conflicting roles in tumor immunology,42 was diminished in edited CD4+ and CD8+ TILs (p ≤ 0.0001 and p ≤ 0.0098, respectively). The gene discussed is CD38; the disease is neoplasm.